HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Daniele Poole Selected Research

Sepsis (Septicemia)

1/2022The PROVENT-C19 registry: A study protocol for international multicenter SIAARTI registry on the use of prone positioning in mechanically ventilated patients with COVID-19 ARDS.
1/2018Mid regional pro-adrenomedullin for the prediction of organ failure in infection. Results from a single centre study.
6/2013[The register GiViTI about the use of the drug Xigris® in the Italian intensive care units].
2/2013Drotrecogin alfa (activated) in severe sepsis.
1/2009Errors in the approval process and post-marketing evaluation of drotrecogin alfa (activated) for the treatment of severe sepsis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Daniele Poole Research Topics

Disease

5Sepsis (Septicemia)
01/2022 - 01/2009
4COVID-19
12/2023 - 11/2021
3Wounds and Injuries (Trauma)
01/2020 - 01/2014
3Infections
10/2018 - 01/2014
2Critical Illness (Critically Ill)
03/2024 - 11/2021
2Chronic Obstructive Pulmonary Disease (COPD)
01/2023 - 12/2017
2Coma (Comas)
04/2022 - 01/2014
1Heart Arrest (Cardiac Arrest)
04/2022
1Pain (Aches)
04/2022
1Pneumothorax
11/2021
1Ventilator-Associated Pneumonia
11/2021
1Respiratory Insufficiency (Respiratory Failure)
12/2020
1Brain Injuries (Brain Injury)
12/2020
1Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage)
01/2020
1Ischemic Stroke
01/2020
1Intracranial Hypertension
01/2020
1Traumatic Cerebral Hemorrhage
01/2020
1Brain Ischemia (Cerebral Ischemia)
01/2018
1Fibrosis (Cirrhosis)
12/2017
1Dementia (Dementias)
12/2017
1Surgical Wound Infection
01/2014

Drug/Important Bio-Agent (IBA)

3drotrecogin alfa activated (Xigris)FDA Link
06/2013 - 01/2009
2Biomarkers (Surrogate Marker)IBA
04/2022 - 01/2018
2Anti-Bacterial Agents (Antibiotics)IBA
10/2018 - 01/2014
1Oxygen (Dioxygen)IBA
12/2023
1cytidylyl-(3'-5')-cytidine (CpC)IBA
04/2022
1Phosphopyruvate Hydratase (Enolase)IBA
04/2022
1Mannitol (Osmitrol)FDA LinkGeneric
01/2020
1Carbapenems (Carbapenem Antibiotics)IBA
10/2018
1Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric
10/2018
1AdrenomedullinIBA
01/2018
1ProcalcitoninIBA
01/2018
1ORALIT (ORS)IBA
12/2017
1Fibrinogen (Factor I)FDA Link
01/2016
1Tranexamic Acid (AMCA)FDA Link
01/2016

Therapy/Procedure

4Critical Care (Surgical Intensive Care)
03/2024 - 12/2020
4Therapeutics
12/2023 - 01/2016
4Resuscitation
10/2022 - 01/2018
3Analgesia
10/2022 - 11/2021
3Anesthesia
10/2022 - 11/2021
2Positive-Pressure Respiration (Positive End-Expiratory Pressure)
01/2023 - 11/2021
2Artificial Respiration (Mechanical Ventilation)
11/2021 - 12/2020
1Cannula
12/2023
1Noninvasive Ventilation
12/2023
1Continuous Positive Airway Pressure
12/2023
1Mechanical Ventilators (Ventilator)
12/2020
1Tracheostomy
12/2020
1Airway Management
12/2020
1Antibiotic Prophylaxis
01/2014